FDA issues generic guidance on GSK’s top-selling asthma drug, Advair – Philly.com (blog)


Yahoo!7 News

FDA issues generic guidance on GSK's top-selling asthma drug, Advair
Philly.com (blog)
PhillyPharma. FDA issues generic guidance on GSK's top-selling asthma drug, Advair. GlaxoSmithKline's top-selling drug by far is the asthma medication Advair, which accounts for about 20 percent of company revenue. Generic competition got a bit closer
GlaxoSmithKline Shares Fall After Advair SetbackWall Street Journal
Glaxo Declines as FDA Clears Path for Advair RivalsBloomberg
New FDA guidance threatens GlaxoSmithKline's AdvairFiercePharma
euronews
all 13 news articles »

View full post on asthma – Google News